Navigation Links
Developing Nations to Get Gardasil at Lesser Rates from Merck Soon

Pharma giant Merck and Co., hopes to offer Gardasil, to developing countries at affordable rates.// Gardasil, marketed by Merck is the only vaccine against Human Papilloma Virus, that is insinuated to cause the deadly cervical cancer.

Statistics reveal that cervical cancer is rampant in developing countries.80% of deaths attributed to cervical cancer is seen to occur in developing nations.

A single dose of Gardasil is priced at 120 €.The vaccination programme advises three doses for effective protection. This does not make it practical for distribution in developing nations.

Merck officials have notified that the company hopes to make the vaccine available in the market at lower prices in developing countries in a couple of months.

Health experts across the globe have been lobbying to make this vaccine available to all young sexually active women, to get protection against HPV which is a sexually transmitted virus. Statistics show that at least 95% women are never get a cervical smear done, without which a positive diagnosis for cervical cancer cannot be reached.

The vaccine is currently available in 13 European Union countries and also in United States. Merck has vouched that they are indeed committed to reduce the usual time lag of about two decades that pass from the date of approval of medicines in the West and the point they reach poorer nations.


MST
'"/>




Page: 1

Related medicine news :

1. Risk Of Developing Arthritis
2. Developing HIV fighter
3. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
4. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
5. Men Who at Risk Of Developing Prostate Cancer
6. Identifying The Risks Of Developing Schizophrenia
7. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
8. Cancer Patients At A Greater Risk Of Developing Blood Clots
9. Young Smokers at Increased Risk Of Developing a Heart Attack
10. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment
11. Individuals Born In May At A Higher Risk Of Developing Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/16/2018)... ... November 16, 2018 , ... The Hong ... Resources Microelectronics Limited (CR Micro) and China Resources Life Science Industry Development ... two joint research centres for novel micro-electronic devices and precision medicine. The ...
(Date:11/15/2018)... ... November 15, 2018 , ... Made of Millions, a nonprofit organization ... — Seen — to New York this month. The event will feature a discussion ... create environment that showcases mental health issues in a more experiential way,” said Aaron ...
(Date:11/15/2018)... ... 15, 2018 , ... Drs. Randolph Waldman, Stephen A. Schantz, ... join their team at Waldman, Schantz, Turner Plastic Surgery Center. The ... is expanding its staff to meet patient demand. These individuals were selected for ...
(Date:11/15/2018)... (PRWEB) , ... November 15, 2018 , ... The National ... 2018. While advancing age is the primary risk factor for cancer and we typically ... people under the age of 45. And with aggressive treatment and advanced therapies, increasing ...
(Date:11/15/2018)... ... November 15, 2018 , ... Associated Urologists of ... Center of Excellence. The designation recognizes that Dr. Dehner has achieved a high ... to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia ...
Breaking Medicine News(10 mins):
(Date:11/15/2018)... ... 15, 2018 , ... According to Nielsen, a leading retail data company, plant-based ... percent, as compared to only a 2 percent growth for all other foods in ... Plant Based World Conference & Expo (PBW) taking place June 7-8, 2019 at the ...
(Date:11/15/2018)... ... November 15, 2018 , ... ... service provider, has completed a transaction with Grand Canyon Anesthesia (“GCA”), a Phoenix-based ... of high-quality care in the Phoenix area,” says Marty Bonick, chief executive officer ...
(Date:11/15/2018)... ... November 15, 2018 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that Pete Young, Director of Quality ... in Clinical Trials (PCT) conference at the CCIB Convention Centre Barcelona, Barcelona, Spain ...
Breaking Medicine Technology: